covovax-
![Single-day rise of 1,549 fresh COVID-19 cases, 31 fatalities in India; active infections continue do-](https://www.cdn.awamkasach.com/uploads/2022/03/Single-day-rise-of-1549-fresh-COVID-19-cases-31-fatalities-in.jpg)
Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and-
By PTI NEW DELHI: The COVID-19 Working Group of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in ...
![Single-day rise of 1,549 fresh COVID-19 cases, 31 fatalities in India; active infections continue do-](https://www.cdn.awamkasach.com/uploads/2022/03/Single-day-rise-of-1549-fresh-COVID-19-cases-31-fatalities-in.jpg)
India’s drugs regulator gives nod to phase-3 clinical trial of Covid vaccine Covovax-
By PTI NEW DELHI: The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical ...
![DCGI's EUA nod to SII's Covovax for 12-17 years age group-](https://www.cdn.awamkasach.com/uploads/2022/03/DCGIs-EUA-nod-to-SIIs-Covovax-for-12-17-years-age.jpg)
DCGI’s EUA nod to SII’s Covovax for 12-17 years age group-
By PTI NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for ...
![Fake vaccination entries, incorrect figures obstruct Punjab's COVID-19 vaccination drive-](https://www.cdn.awamkasach.com/uploads/2022/02/Fake-vaccination-entries-incorrect-figures-obstruct-Punjabs-COVID-19-vaccination-drive.jpg)
Government panel recommends EUA for Covid vaccine Covovax for 12-17 age group-
By PTI NEW DELHI: An expert panel of the country’s central drug authority has recommended granting emergency use authorisation (EUA) ...
![Fake vaccination entries, incorrect figures obstruct Punjab's COVID-19 vaccination drive-](https://www.cdn.awamkasach.com/uploads/2022/02/Fake-vaccination-entries-incorrect-figures-obstruct-Punjabs-COVID-19-vaccination-drive.jpg)
Serum Institute seeks EUA for its Covovax vaccine for 12-17 years age group-
By PTI NEW DELHI: Serum Institute of India has sought emergency use authorisation from India’s drug regulator for its COVID-19 ...
![Corbevax, Covovax, Molnupiravir approved for restricted emergency use against COVID-](https://www.cdn.awamkasach.com/uploads/2021/12/Corbevax-Covovax-Molnupiravir-approved-for-restricted-emergency-use-against-COVID.jpg)
Boost for India’s COVID fight as country approves vaccines Corbevax, Covovax and Molnupiravir pill-
By PTI NEW DELHI: Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s COVID-19 ...
![Corbevax, Covovax, Molnupiravir approved for restricted emergency use against COVID-](https://www.cdn.awamkasach.com/uploads/2021/12/Corbevax-Covovax-Molnupiravir-approved-for-restricted-emergency-use-against-COVID.jpg)
Corbevax, Covovax, Molnupiravir approved for restricted emergency use against COVID-
By PTI NEW DELHI: Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved ...
![Israel trials fourth dose of COVID-19 vaccine-](https://www.cdn.awamkasach.com/uploads/2021/12/Israel-trials-fourth-dose-of-COVID-19-vaccine.jpg)
Government panel recommends EUA for vaccines Covovax, Corbevax and anti-Covid pill molnupiravir-
By PTI NEW DELHI: An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to ...
![Serum Institute's Covovax vaccine gets WHO emergency use nod, Poonawalla hails decision-](https://www.cdn.awamkasach.com/uploads/2021/12/Serum-Institutes-Covovax-vaccine-gets-WHO-emergency-use-nod-Poonawalla-hails.jpg)
Serum Institute’s Covovax vaccine gets WHO emergency use nod, Poonawalla hails decision-
By PTI NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla on Friday hailed WHO’s approval for emergency use ...
![Covovax not yet been approved in country of origin: Govt panel seeks additional data from Serum Inst-](https://www.cdn.awamkasach.com/uploads/2021/11/Covovax-not-yet-been-approved-in-country-of-origin-Govt-panel.jpg)
Covovax not yet been approved in country of origin: Govt panel seeks additional data from Serum Inst-
By PTI NEW DELHI: An expert panel of India’s Central Drug Authority, which recently reviewed Serum Institute’s application seeking emergency ...